These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1362630)

  • 21. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.
    Nelson KE; Galai N; Safaeian M; Strathdee SA; Celentano DD; Vlahov D
    Am J Epidemiol; 2002 Oct; 156(7):641-53. PubMed ID: 12244033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive reserve during neuropsychological performance in HIV intravenous drug users.
    Vázquez-Justo E; Blanco AP; Vergara-Moragues E; Gestoso CG; Pérez-García M
    Appl Neuropsychol Adult; 2014; 21(4):288-96. PubMed ID: 25265310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive behavior in asymptomatic (CDC stage II and III) HIV--seropositive intravenous drug users (IVDUs).
    Del Pesce M; Franciolini B; Censori B; Bartolini M; Ancarani F; Petrelli E; Provinciali L
    Ital J Neurol Sci; 1993 Dec; 14(9):619-25. PubMed ID: 8125764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the revised surveillance definition: AIDS among New York City drug users.
    Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M; Yancovitz S; Beatrice S
    Am J Public Health; 1992 Nov; 82(11):1531-3. PubMed ID: 1359800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1, cocaine, and neuropsychological performance in African American men.
    Durvasula RS; Myers HF; Satz P; Miller EN; Morgenstern H; Richardson MA; Evans G; Forney D
    J Int Neuropsychol Soc; 2000 Mar; 6(3):322-35. PubMed ID: 10824504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury.
    Marder K; Stern Y; Malouf R; Tang MX; Bell K; Dooneief G; el-Sadr W; Goldstein S; Gorman J; Richards M
    Arch Neurol; 1992 Nov; 49(11):1169-75. PubMed ID: 1444884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study.
    Starace F; Baldassarre C; Biancolilli V; Fea M; Serpelloni G; Bartoli L; Maj M
    Acta Psychiatr Scand; 1998 Feb; 97(2):132-8. PubMed ID: 9517907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of HIV/AIDS among African American intravenous drug users: implication for public health policy.
    Coleman CL
    ABNF J; 2004; 15(5):94-6. PubMed ID: 15532242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.
    Bornstein RA; Fama R; Rosenberger P; Whitacre CC; Para MF; Nasrallah HA; Fass RJ
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):254-9. PubMed ID: 8369633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control.
    Allen DM; Onorato IM; Green TA
    Am J Public Health; 1992 Apr; 82(4):541-6. PubMed ID: 1312310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men.
    Palenicek J; Nelson KE; Vlahov D; Galai N; Cohn S; Saah AJ
    Arch Intern Med; 1993 Aug; 153(15):1806-12. PubMed ID: 8101438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients.
    McKegney FP; O'Dowd MA; Feiner C; Selwyn P; Drucker E; Friedland GH
    AIDS; 1990 Jun; 4(6):565-9. PubMed ID: 2386618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.
    van Haastrecht HJ; van Ameijden EJ; van den Hoek JA; Mientjes GH; Bax JS; Coutinho RA
    Am J Epidemiol; 1996 Feb; 143(4):380-91. PubMed ID: 8633622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slowed reaction time in HIV-1-seropositive intravenous drug users without AIDS.
    Ayuso-Mateos JL; Pereda M; Gómez Del Barrio A; Echevarria S; Fariñas MC; García-Palomo D
    Eur Neurol; 2000; 44(2):72-8. PubMed ID: 10965157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users.
    Hestad K; Aukrust P; Ellertsen B; Kløve H; Wilberg K
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):732-42. PubMed ID: 8276932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Arch Intern Med; 2001 May; 161(10):1281-8. PubMed ID: 11371255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive risk factors and neuropsychological performance in HIV infection.
    Claypoole KH; Townes BD; Collier AC; Marra C; Longstreth WT; Cohen W; Martin D; Coombs RW; Goldstein D; Sanchez P
    Int J Neurosci; 1993 May; 70(1-2):13-27. PubMed ID: 8083020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.